Robinson Gregory Scott 4/A
4/A · Nightstar Therapeutics plc · Filed Jan 9, 2019
Insider Transaction Report
Form 4/AAmended
Robinson Gregory Scott
Chief Scientific Officer
Transactions
- Sale
Ordinary Shares
2019-01-02$11.15/sh−14,764$164,619→ 104,017 total
Footnotes (3)
- [F1]The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person
- [F3]On January 4, 2019, a Form 4 was filed to report the January 2, 2019 sale of 14,764 ordinary shares pursuant a 10b5-1 plan previously adopted by the Reporting Person. The report provided by the Issuer's equity administrator contained errors relating to the Reporting Person's holdings which have been corrected herein. This Form 4/A amends and restates, in its entirety, the original Form 4.